John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.

We’re working to bring the hope of advanced medicine to more patients.

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

Targeting inflammation to fight cancer is a new approach with a long history.

Lutz Hegemann shares how lessons learned treating patients with leprosy influenced the way he thinks about the pharmaceutical business.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.